Literature DB >> 19473462

Anxiety disorders in patients with idiopathic priapism: risk factor and pathophysiologic link?

Arthur L Burnett1.   

Abstract

INTRODUCTION: A scientific explanation remains elusive for many presentations of recurrent ischemic priapism. AIM: The aim of this article was to evaluate the possible clinical association between idiopathic priapism and anxiety disorders.
METHODS: Twenty-one patients without identifiable, presumed etiologies for their priapism disorders presented consecutively to a single practitioner's clinical practice and underwent clinical history evaluation and management over a 2(1/2)-year interval. MAIN OUTCOME MEASURES: The main outcome is the documentation of patient demographics and clinical profiles relating to medical history and priapism presentations.
RESULTS: Anxiety disorders including generalized anxiety, attention-deficit hyperactivity disorder, and obsessive-compulsive disorder were self-reported in 10 patients.
CONCLUSIONS: The possible association between idiopathic priapism and anxiety disorders lends support for a central neurobiologic pathophysiology for the erectile disorder. Further neuropsychiatric studies of this clinical population is required to confirm the hypothesis.

Entities:  

Mesh:

Year:  2009        PMID: 19473462     DOI: 10.1111/j.1743-6109.2009.01246.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  3 in total

1.  Priapism Impact Profile Questionnaire: Development and Initial Validation.

Authors:  Arthur L Burnett; Uzoma A Anele; Leonard R Derogatis
Journal:  Urology       Date:  2015-04-08       Impact factor: 2.649

2.  Anxiety related to sexual abuse: A case of recurrent priapism.

Authors:  Allan Abbass; John Grantmyre; Robin L Kay
Journal:  Can Urol Assoc J       Date:  2013 Jan-Feb       Impact factor: 1.862

Review 3.  ADHD in children and youth: Part 2-Treatment.

Authors:  Mark E Feldman; Alice Charach; Stacey A Bélanger
Journal:  Paediatr Child Health       Date:  2018-10-24       Impact factor: 2.253

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.